EIF5A2 抗体
Quick Overview for EIF5A2 抗体 (ABIN1497996)
抗原
See all EIF5A2 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
- 
    - 
                                            特异性
- Human EIF5A2
- 
                                            纯化方法
- Protein A/G purified
- 
                                            免疫原
- 
                        Full length human recombinant protein of human EIF5A2(NP_065123) produced in HEK293T cell.
 Type of Immunogen: Recombinant protein
- 
                                            亚型
- IgG1
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- Approved: Flo (1:100), IF (1:100), IHC, IHC-P (1:150), WB (1:2000)
- 
                                            说明
- 
                        Target Species of Antibody: Human 
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            状态
- Liquid
- 
                                            浓度
- Lot specific
- 
                                            缓冲液
- PBS, pH 7.3, 1 % BSA, 50 % glycerol, 0.02 % sodium azide
- 
                                            储存液
- Sodium azide
- 
                                            注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            储存条件
- -20 °C
- 
                                            储存方法
- Store at -20°C. Avoid freeze-thaw cycles.
 
- 
                                            
- 
    - EIF5A2 (Eukaryotic Translation Initiation Factor 5A2 (EIF5A2))
- 
                                            别名
- EIF5A2
- 
                                            背景
- 
                        Name/Gene ID: EIF5A2
 Synonyms: EIF5A2, EIF-5A-2, EIF-5A2, EIF5AII
- 
                                            基因ID
- 56648
- 
                                            NCBI登录号
- NP_065123
 抗原
- 
                    
 
                                     
                                     
                                    